Dr. Kasra Amirdelfan, MD

  • Walnut Creek, CA
  • Pain medicine physician
NPI1033113642PAC ID6709879737
Medicare services, 2023
42
Part D claims, 2021
139
Publications
74
Clinical trials
6
Industry payments
$1.3M
Practice address
450 N Wiget Ln, Walnut Creek, CA 94598-2408
Practice phone
Call (925) 482-8151
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Boomerang Healthcare

Multi-specialty group site · Walnut Creek, California

Find Dr. Amirdelfan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kasra Amirdelfan is a pain medicine physician in Walnut Creek, California

Dr. Amirdelfan practices at Boomerang Healthcare in Walnut Creek, California.

Dr. Amirdelfan's NPI, 1033113642, was assigned on June 10, 2005. Dr. Amirdelfan graduated from Texas a & M University System, Hsc, College of Medicine in 1994. Dr. Amirdelfan holds California license A66427.

NPI and contact details
Medicare PAC ID
6709879737
NPI enumeration date
June 10, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(925) 482-8151
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
58
Medical school graduation
1994

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kasra Amirdelfan practices at Boomerang Healthcare in Walnut Creek, California

Dr. Amirdelfan's primary practice is Boomerang Healthcare, at 450 N Wiget Ln, Walnut Creek, CA 94598-2408. The practice phone is (925) 482-8151.

  • Boomerang Healthcare
    450 N Wiget Ln, Walnut Creek, CA 94598-2408Phone(925) 482-8151

Source: Dmand AI Affiliation Data

Dr. Kasra Amirdelfan is affiliated with 1 site of care and 1 medical group

Dr. Amirdelfan's primary practice is Boomerang Healthcare in Walnut Creek, California. The medical group on file is Boomerang Healthcare.

Boomerang HealthcareMulti-specialty group site · Walnut Creek, CaliforniaPrimary
Boomerang HealthcareBehavioral and mental health group, Walnut Creek, CA

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Kasra Amirdelfan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amirdelfan practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Boomerang HealthcareAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Amirdelfan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kasra Amirdelfan is one of 118 pain medicine physicians in California

Pain medicine is Dr. Amirdelfan's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Amirdelfan is licensed in California.

Specialties and state licenses

  • Pain medicine, CaliforniaPrimaryLicense A66427 · taxonomy 208VP0000X

Pain medicine physicians near Dr. Amirdelfan

Counts of pain medicine physicians with a Dmand AI profile, by place and practice. Each opens the list.

118pain medicine physicians in California
5pain medicine physicians in Walnut Creek

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kasra Amirdelfan billed Medicare for 42 services in 2023

CMS data shows 42 Medicare services from Dr. Amirdelfan across 1 procedure code in 2023. Medicare paid $9,931 for them. Every service was in an office.

Medicare services, 202342
Paid by Medicare$9,931
Procedure codes1

Dr. Amirdelfan's Medicare services by type, 2022 to 2023

  • 2022
  • 2023
Other services
2022: 4712023: 4291%
Tests and treatments
2022: 1,7452023: 0100%
Office and hospital visits
2022: 2,0572023: 0100%

Dr. Amirdelfan compared with the California median for pain medicine physicians, 2023

  • Dr. Amirdelfan
  • California median
Medicare services
42vs 1,37197% below
Part D claims
139vs 33559% below

Medians across 118 pain medicine physicians in California with Dmand AI profiles that report each measure.

Dr. Amirdelfan's most billed Medicare procedure codes, 2023

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Amirdelfan

Need commercial claims for Dr. Amirdelfan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Amirdelfan and other pain medicine physicians in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kasra Amirdelfan's patients have a median age of 67

Across all payers, Dmand AI patient panel data puts Dr. Amirdelfan's median patient age at 67, with 67% women.

Dr. Amirdelfan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women67%
  • Men28%

Source: Dmand AI Patient Panel Data

Dr. Kasra Amirdelfan wrote 139 Medicare Part D claims in 2021

In 2021, Dr. Amirdelfan wrote 139 Medicare Part D claims. They cover 6 drugs, with $2,795 in total drug cost. In 2020, CMS named 446 claims across 15 drugs.

Part D claims, 2021139
Drugs named by CMS6
Total drug cost$2,795

Dr. Amirdelfan's most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2021

  • 2020
  • 2021
Claims for drugs CMS names
2020: 4462021: 13969%

Drugs named by CMS: 6 in 2021, 15 in 2020.

See all prescribing by Dr. Amirdelfan

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

How Dr. Kasra Amirdelfan takes part in Medicare

Dr. Amirdelfan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find pain medicine physicians like Dr. Amirdelfan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kasra Amirdelfan has 74 publications on record

Dmand AI links 74 papers to Dr. Amirdelfan, published from 2014 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Spinal Cord Stimulation, Chronic Pain and Pain Measurement. Dr. Amirdelfan has published most often in Neuromodulation. Dr. Amirdelfan's most frequent co-authors are Timothy Ray Deer, MD, Dawood Sayed, MD and Leonardo Kapural, MD.

Papers74
Years published2014 to 2025

Dr. Amirdelfan's papers by year, 2014 to 2025

Topics Dr. Amirdelfan writes about most

  • Spinal Cord Stimulation
  • Chronic Pain
  • Pain Measurement
  • Pain Management
  • Spinal Cord
  • Low Back Pain
  • Intervertebral Disc Degeneration
  • Ganglia, Spinal

Dr. Amirdelfan's most frequent co-authors

Recent publications by Dr. Amirdelfan

See all 74 publications and co-authors

See who Dr. Amirdelfan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Amirdelfan works with, so you can find a warm path to the right pain medicine physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kasra Amirdelfan has worked on 6 clinical trials

Dmand AI links Dr. Amirdelfan to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Low Back Pain, Back Pain and Intervertebral Disc Degeneration. SPR Therapeutics, Inc. sponsors the most, 2.

Conditions in Dr. Amirdelfan's trials

  • Low Back Pain
  • Back Pain
  • Intervertebral Disc Degeneration
  • Chronic Pain
  • Pain

Investigators on the most trials with Dr. Amirdelfan

Recent clinical trials with Dr. Amirdelfan

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kasra Amirdelfan received $1,292,615 in industry payments from 2016 to 2025

CMS Open Payments shows 1,624 general payments to Dr. Amirdelfan from 53 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Nevro Corp. paid the most, $999,598. It also lists 6 research payments totaling $6,149 from 2018 to 2021.

General payments to Dr. Amirdelfan by program year, 2016 to 2025

General payments to Dr. Amirdelfan by kind, 2016 to 2025

$1.3Min total
  • Consulting fees$475,52937%
  • Education speaker fees$368,28129%
  • Speaker and faculty fees$164,19413%
  • Travel and lodging$131,23110%
  • Other$129,98710%

Companies that paid Dr. Amirdelfan the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Amirdelfan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kasra Amirdelfan graduated from Texas a & M University System, Hsc, College of Medicine

Dr. Amirdelfan graduated from Texas a & M University System, Hsc, College of Medicine in 1994.

  1. Medical schoolTexas a & M University System, Hsc, College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Kasra Amirdelfan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kasra Amirdelfan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kasra Amirdelfan's NPI number?

Dr. Kasra Amirdelfan's NPI number is 1033113642. It was assigned on June 10, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Kasra Amirdelfan?

Dr. Kasra Amirdelfan is a pain medicine physician in Walnut Creek, California. The primary specialty in the NPI Registry is Pain Medicine Physician (taxonomy code 208VP0000X).

Where does Dr. Kasra Amirdelfan practice?

Dr. Amirdelfan practices at 450 N Wiget Ln, Walnut Creek, CA 94598-2408. Dr. Amirdelfan's primary practice is Boomerang Healthcare in Walnut Creek, California.

What is Dr. Kasra Amirdelfan's office phone number?

The practice phone on file for Dr. Amirdelfan is (925) 482-8151.

What is Dr. Kasra Amirdelfan's medical license number?

Dr. Amirdelfan holds California license A66427.

What medical group is Dr. Kasra Amirdelfan part of?

Dr. Amirdelfan is linked to Boomerang Healthcare.

Does Dr. Kasra Amirdelfan accept Medicare?

Yes. CMS data shows Dr. Amirdelfan billed Medicare for 42 services in 2023, and Dr. Amirdelfan accepts Medicare assignment.

What services does Dr. Kasra Amirdelfan bill to Medicare?

In 2023, Dr. Amirdelfan's most billed Medicare services were medicare service (G0483).

Where did Dr. Kasra Amirdelfan go to medical school?

Dr. Amirdelfan graduated from Texas a & M University System, Hsc, College of Medicine in 1994.

What drugs does Dr. Kasra Amirdelfan prescribe most?

In 2021 Medicare Part D data, Dr. Amirdelfan's most prescribed drugs by claims were Cephalexin, Hydrocodone-Acetaminophen and Gabapentin.

Show 4 more questionsShow fewer questions

Has Dr. Kasra Amirdelfan received payments from drug or device companies?

CMS Open Payments shows $1,292,615 in general payments to Dr. Amirdelfan from 53 companies from 2016 to 2025. The largest total came from Nevro Corp.

How long has Dr. Kasra Amirdelfan been practicing?

Dr. Amirdelfan graduated from medical school in 1994, 32 years ago.

Does Dr. Kasra Amirdelfan do research?

Dmand AI links 74 publications to Dr. Amirdelfan, published from 2014 to 2025. Dr. Amirdelfan has worked on 6 clinical trials.

Who does Dr. Kasra Amirdelfan publish with?

Dr. Amirdelfan's most frequent co-authors are Timothy Ray Deer, MD (35 shared papers), Dawood Sayed, MD (25 shared papers) and Leonardo Kapural, MD (24 shared papers).

Selling to pain medicine practices?

See pain medicine physicians in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)